Alisertib is an orally available Drug with potential antineoplastic activity. It is a selective inhibitor of aurora A kinase developed by Takeda. Reference standards of Alisertib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
No Data Found
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
